Acute cholestatic hepatitis associated with levofloxacin;Hepatitis colestásica aguda asociada a levofloxacino

Gastroenterologia y Hepatologia

Volumn 34, Issue 5, 2011, Pages 369-370

  Titos Arcos, José Carlos ^a   Hallal, Hacibe ^a   Robles, Mercedes ^b   Andrade, Raúl J ^b  

^a HOSPITAL MORALES MESEGUER   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOFLOXACIN;

CHOLESTATIC HEPATITIS; DISEASE ASSOCIATION; LETTER;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHOLESTASIS, INTRAHEPATIC; DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; MIDDLE AGED; OFLOXACIN;

EID: 79955969512     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2011.01.011     Document Type: Letter

References (15)

1. Hautekeete M.L., Kockx M.M., Naegels S., Holvoet J.K., Hubens H., Klöppel G. Cholestasic hepatitis related to quinolones: a report of two cases. J Hepatology. 1995, 23:759-760.
2. Robles M., Toscano E., Cotta J., Lucena M.I., Andrade R.J. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Curr Drug Saf. 2009, 5:212-222.
3. Bertino J., Fish D.N. The safety profile of the fluorquinolones. Clin Ther. 2000, 22:798-817.
4. Fish D.N., Crown A.T. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet. 1997, 32:101-119.
5. Bénichou C. Report of an International Consensus Meeting. Criteria of drug-induced liver disorders. J Hepatol 1990, 11:272-276.
6. Danan G., Bénichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol. 1993, 46:1323-1330.
7. Schulwalm J.D., Lee C.H. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. CMAJ. 2003, 168:847-848.
8. Norrby S.R., Petermann W., Willcox P.A., Vetter N., Salewski E. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scan J Infect Dis. 1998, 30:397-404.
9. Suzuki A., Andrade J., Bjornsson E., Lucena M.I., Lee W.M., Yuen N.A., et al. International collaborative work: a unified list of drugs associated with hepatotoxicity and the reporting frequency of liver events in the Who database. Drug Saf. 2010, 33:503-522.
10. Karim A., Ahmed S., Rossoff L.J., Siddiqui R.K., Steinberg H.N. Possible levofloxacin-induced acute hepatocellular injury in a patient with chronic obstructive lung disease. Clin Infect Dis. 2001, 33:2088-2090.
11. Spahr L., Rubbia-Brandt L., Marinescu O., Armenian B., Hadengue A. Acute fatal hepatitis related to levofloxacin. J Hepatol. 2001, 35:308-309.
12. Çoban Ş., Ceydilek B., Ekiz F., Erden E., Soykan I. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection. Ann Pharmacother. 2005, 39:1737-1740.
13. Heluwaert F., Roblin X., Duffournet V., Capony P., Martin D., Roblin X. Hepatitis related to amoxicillin or levofloxacin: a case report. Rev Med Interne. 2003, 24:841-843.
14. Carrascosa M.F., Lucena M.I., Andrade R.J., Caviedes J.R., Lavín A.C., Mones J.C., et al. Fatal acute hepatitis after sequential treatment with levofloxacin, doxycycline, and naproxen in a patient presenting with acute Mycoplasma pneumoniae infection. Clin Ther. 2009, 31:1014-1019.
15. García-Aparicio J., Herrero-Herrero J.I. Hepatitis tóxica tras tratamiento secuencial con cotrimoxazol, levofloxacino, doxiciclina y sertralina en paciente con infección respiratoria. Farm Hosp. 2010, 34:152-154.